NASDAQ: SNTI Senti Biosciences Holdings, Inc. 8-K

Senti Biosciences reports Q1 2026 results, announces SENTI-202 clinical and regulatory update

Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNTI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 4:56 PM